A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study

Research output: Contribution to journalArticle

  • Authors:
  • Yung-Jue Bang
  • E. Van Cutsem
  • W Mansoor
  • Russell Petty
  • Y. Chao
  • And 7 others
  • External authors:
  • David Cunningham
  • David Ferry
  • Donal Landers
  • Paul K. Stockman
  • N Smith
  • C Geh
  • Elaine Kilgour

Bibliographical metadata

Original languageEnglish
JournalJournal of Clinical Oncology
Volume33
Issue number15
Publication statusPublished - 31 Jan 2017